The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17. "Although the overall risk of being infected with mpox for the general EU population remains low,

LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in adolescents, bolstering the case for using the shot in the 12 to 17 age group to contain an outbreak in parts of Africa.

The European Commission has approved Bavarian Nordic's (OTCPK:BVNRY)(OTCPK:BVNKF) mpox shot for adolescents between 12 and 17 years old. Approval was based on data from a clinical study of more than 300 adolescents and 200 adults that found non-inferior immune responses and similar safety profile between both age groups after two standard doses

The mpox outbreak in Africa is still not under control, the Africa Centres for Disease Control and Prevention (Africa CDC) warned on Thursday, adding that cases were still increasing in several countries.

Mpox is not under control in Africa, the Africa Centres for Disease Control and Prevention (CDC) said on Thursday. Within a week, almost 3,000 new suspected cases of the disease were reported in Africa,

Within one week, 2,912 new cases were documented compared to the previous week, with Morocco reporting its first case, confirming the spread of the disease in all four regions of the continent. The Africa Centres for Disease Control and Prevention (Africa CDC) has raised concerns that the Mpox outbreak in Africa remained uncontrolled,